Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Tim Barabe, Lewis Shuster

Premium

Former Affymetrix CFO Tim Barabe has joined the board of directors of Opexa Therapeutics, a Woodlands, Texas-based biotechnology company.

Barabe retired from his role as CFO and executive vice president last year. Before joining the microarray vendor, he was also CFO of Human Genome Sciences and Regent Medical Ltd.

Barabe also serves on the board of ArQule, a Boston-based biotech company, Opexa said.


HTG Molecular Diagnostics has appointed Lewis Shuster to its board of directors.

Shuster is CEO of Shuster Capital, a strategic and operating advisory firm to life science company executives and investors based in Encinitas, Calif. He served previously as president of Invitrogen's Genomics division, CEO of Kemia, as well as CFO of Human Genome Sciences and Pharmacopeia.

He is currently a board member with Response Biomedical, Mast Therapeutics, Cleave Biosciences and MSN Healthcare.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.